IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Foresite Capital Opportunity Management V, LLC

Q3 2022 Holdings

Filed 2022-11-14 | 9 holdings | $3.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Compass Therapeutics, Inc.(CMPX)COM20454B104$3.5M1,554,25099.2%
Pardes Biosciences IncCOM69945Q105$9.7K5,227,3070.3%
Theseus Pharmaceuticals, Inc.COM88369M101$5.6K959,2750.2%
Gemini Therapeutics, Inc.COM36870G105$4.0K2,435,1250.1%
Kinnate Biopharma Inc.COM49705R105$3.5K291,6670.1%
Adicet Bio, Inc.(TORCEUR)COM007002108$2.4K170,0000.1%
Quantum-Si Incorporated(QSI)COM CL A74765K105$1.7K633,6260.0%
Hims & Hers Health, Inc.(HIMS)COM CL A433000106$1.7K306,4310.0%
Enanta Pharmaceuticals, Inc.(ENTA)COM29251M106$1.2K22,7500.0%